Announcements Trials
Browse Landscape

Phase

Phase NA 14Phase 2 11Phase EARLY_PHASE1 3Phase 1 3Phase 1/2 2Phase 3 1Phase 2/3 1

Status

Recruiting 7Terminated 4Completed 3Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1NET 1Lymphoid 1Gastrointestinal 1Endocrine 1

Conditions

Pancreatic Ductal Adenocarcinoma 1Neuroendocrine Tumors 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1

Interventions

Paclitaxel 291Gemcitabine 254Carboplatin 253Cisplatin 250Radiotherapy 219Cyclophosphamide 218Irinotecan 184pembrolizumab 180Docetaxel 174Bevacizumab 166Capecitabine 148Nivolumab 141Fluorouracil 132Dexamethasone 125Bortezomib 123Oxaliplatin 115Cytarabine 113Erlotinib Hydrochloride 112Temozolomide 110Sorafenib 110Doxorubicin 106Rituximab 105Leucovorin 105Etoposide 105Filgrastim 99Everolimus 97Lenalidomide 95Ipilimumab 90Pemetrexed 89fludarabine phosphate 84

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Completed × Positron Emission Tomography Computed Tomography × Clear all
NCT03851237 2026-05-08

CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy

Washington University School of Medicine

Phase 1 Completed
69 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT03883776 2020-09-09

Al18F-NOTA-octreotide PET Imaging of the Somatostatin Receptor in Neuroendocrine Tumors

Universitaire Ziekenhuizen KU Leuven

Phase 1 Completed
12 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT00588328 2015-12-24

The Use of Breathing Synchronized CT and PET Scans in Radiation Therapy Treatment Planning

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
35 enrolled
LymphoidThoracic

Lung Neoplasms, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡